IL1B and infection: Previous studies have suggested that interleukins may inhibit the degree of infection caused by pathogenic bacteria by promoting the aggregation and activation of inflammatory cells (26); moreover, IL-1β and IL-18 can also stimulate NET activation in neutrophils to cause changes in the immune microenvironment and accelerate the dysbiosis of oral flora (27–29).